{"id":"https://openalex.org/W4251672557","doi":"https://doi.org/10.1037//1064-1297.5.2.119","title":"Ibogaine interferes with the establishment of amphetamine place preference learning.","display_name":"Ibogaine interferes with the establishment of amphetamine place preference learning.","publication_year":1997,"publication_date":"1997-01-01","ids":{"openalex":"https://openalex.org/W4251672557","doi":"https://doi.org/10.1037//1064-1297.5.2.119","pmid":"https://pubmed.ncbi.nlm.nih.gov/9234047"},"language":"en","primary_location":{"id":"doi:10.1037//1064-1297.5.2.119","doi":"https://doi.org/10.1037//1064-1297.5.2.119","is_oa":false,"landing_page_url":"https://doi.org/10.1037//1064-1297.5.2.119","pdf_url":null,"source":{"id":"https://openalex.org/S357931","display_name":"Experimental and Clinical Psychopharmacology","issn_l":"1064-1297","issn":["1064-1297","1936-2293"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320262","host_organization_name":"American Psychological Association","host_organization_lineage":["https://openalex.org/P4310320262"],"host_organization_lineage_names":["American Psychological Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental and Clinical Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060410354","display_name":"Isabella Moroz","orcid":"https://orcid.org/0000-0003-2218-7585","observed_orcids":["https://orcid.org/0000-0003-2218-7585"]},"institutions":[{"id":"https://openalex.org/I75381157","display_name":"Wilfrid Laurier University","ror":"https://ror.org/00fn7gb05","country_code":"CA","type":"education","lineage":["https://openalex.org/I75381157"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Isabella Moroz","raw_affiliation_strings":["Department of Psychology, Wilfrid Laurier University, Waterloo, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychology, Wilfrid Laurier University, Waterloo, Ontario, Canada","institution_ids":["https://openalex.org/I75381157"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079132615","display_name":"Linda A. Parker","orcid":"https://orcid.org/0000-0002-3494-9754","observed_orcids":["https://orcid.org/0000-0002-3494-9754"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Linda A. Parker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5074692242","display_name":"Shepard Siegel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shepard Siegel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5825,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.62617215,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"5","issue":"2","first_page":"119","last_page":"122"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9067000150680542,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9067000150680542,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12553","display_name":"Psychedelics and Drug Studies","score":0.06289999932050705,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12649","display_name":"Alkaloids: synthesis and pharmacology","score":0.010999999940395355,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ibogaine","display_name":"ibogaine","score":1.0},{"id":"https://openalex.org/keywords/amphetamine","display_name":"amphetamine","score":0.9959999918937683},{"id":"https://openalex.org/keywords/place-preference","display_name":"place preference","score":0.9430000185966492},{"id":"https://openalex.org/keywords/drug-self-administration","display_name":"self-administration","score":0.7039999961853027},{"id":"https://openalex.org/keywords/amphetamine-induced-locomotor-activity","display_name":"amphetamine-induced locomotor activity","score":0.4230000078678131}],"concepts":[{"id":"https://openalex.org/C2777193897","wikidata":"https://www.wikidata.org/wiki/Q179452","display_name":"Amphetamine","level":3,"score":0.8366740942001343},{"id":"https://openalex.org/C2781249084","wikidata":"https://www.wikidata.org/wiki/Q908656","display_name":"Preference","level":2,"score":0.6474465131759644},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5983843803405762},{"id":"https://openalex.org/C35124327","wikidata":"https://www.wikidata.org/wiki/Q5159285","display_name":"Conditioned place preference","level":3,"score":0.49950313568115234},{"id":"https://openalex.org/C2776145449","wikidata":"https://www.wikidata.org/wiki/Q1706418","display_name":"Dextroamphetamine","level":4,"score":0.4897048771381378},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.4220079183578491},{"id":"https://openalex.org/C180747234","wikidata":"https://www.wikidata.org/wiki/Q23373","display_name":"Cognitive psychology","level":1,"score":0.3910173177719116},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.20525670051574707},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.12396112084388733},{"id":"https://openalex.org/C175444787","wikidata":"https://www.wikidata.org/wiki/Q39072","display_name":"Microeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000661","descriptor_name":"Amphetamine","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D000661","descriptor_name":"Amphetamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003216","descriptor_name":"Conditioning, Operant","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004361","descriptor_name":"Drug Tolerance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007050","descriptor_name":"Ibogaine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011619","descriptor_name":"Psychotropic Drugs","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1037//1064-1297.5.2.119","doi":"https://doi.org/10.1037//1064-1297.5.2.119","is_oa":false,"landing_page_url":"https://doi.org/10.1037//1064-1297.5.2.119","pdf_url":null,"source":{"id":"https://openalex.org/S357931","display_name":"Experimental and Clinical Psychopharmacology","issn_l":"1064-1297","issn":["1064-1297","1936-2293"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320262","host_organization_name":"American Psychological Association","host_organization_lineage":["https://openalex.org/P4310320262"],"host_organization_lineage_names":["American Psychological Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental and Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"doi:10.1037/1064-1297.5.2.119","doi":"https://doi.org/10.1037/1064-1297.5.2.119","is_oa":false,"landing_page_url":"https://doi.org/10.1037/1064-1297.5.2.119","pdf_url":null,"source":{"id":"https://openalex.org/S357931","display_name":"Experimental and Clinical Psychopharmacology","issn_l":"1064-1297","issn":["1064-1297","1936-2293"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320262","host_organization_name":"American Psychological Association","host_organization_lineage":["https://openalex.org/P4310320262"],"host_organization_lineage_names":["American Psychological Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental and Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:9234047","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9234047","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental and clinical psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8048999905586243}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W301132502","https://openalex.org/W1029965490","https://openalex.org/W1513316383","https://openalex.org/W1781516445","https://openalex.org/W1956616167","https://openalex.org/W2151862550"],"related_works":["https://openalex.org/W7019628516","https://openalex.org/W2018597789","https://openalex.org/W2036830485","https://openalex.org/W1974364441","https://openalex.org/W2055046158","https://openalex.org/W4234691134","https://openalex.org/W2048137784","https://openalex.org/W2035693707","https://openalex.org/W2080741942","https://openalex.org/W2137660200"],"abstract_inverted_index":{"The":[0,46],"ability":[1],"of":[2,13,23,28,49,60,63],"ibogaine,":[3],"injected":[4],"24":[5],"hr":[6],"before":[7],"amphetamine,":[8],"to":[9,56,65],"modify":[10],"the":[11,26,58,61],"establishment":[12,27],"amphetamine-induced":[14],"place":[15,30],"preference":[16,31],"learning":[17],"was":[18,40],"assessed.":[19],"A":[20],"single":[21],"injection":[22],"ibogaine":[24,50],"blocked":[25],"amphetamine":[29],"after":[32,43],"1":[33],"or":[34],"2":[35],"conditioning":[36,53],"trials,":[37],"but":[38],"it":[39],"less":[41],"effective":[42],"4":[44],"trials.":[45],"reduced":[47],"effectiveness":[48],"across":[51],"multiple":[52],"trials":[54],"appears":[55],"be":[57],"result":[59],"development":[62],"tolerance":[64],"ibogaine.":[66]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2022-05-12T00:00:00"}